Evidence map›Paper›PMID 2670957›Full record

ArticleThe Journal of cell biology1989

An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin.

J V Garcia, B D Gehm, M R Rosner

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Insulysin: an allosteric enzyme as a target for Alzheimer's disease.Journal of molecular neuroscience : MN · 2005
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Growth factors in invertebrate in vitro culture.In vitro cellular & developmental biology : journal of the Tissue Culture Association · 1991
    Review
  17. Native avian c-erbB gene expresses a secreted protein product corresponding to the ligand-binding domain of the receptor.Proceedings of the National Academy of Sciences of the United States of America · 1991
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J V GarciaFred Hutchinson Cancer Research Center, Seattle, Washington 98104.
B D Gehm
M R Rosner
Fred Hutch Cancer Center · US

Funding

TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Matthew J Brady · 2013 to 2026
$20.9M
MODULATION OF CELLULAR PHOSPHORYLATION BY TUMOR PROMOTERR01CA035541 · NCI · UNIVERSITY OF CHICAGO · PI ROSNER, MARSHA R · 1985 to 1995
–
NCI NIH HHS CA35541NIDDK NIH HHS DK20595
6 · The paper itself

Abstract

A single enzyme found in both Drosophila and mammalian cells is able to selectively bind and degrade transforming growth factor (TGF)-alpha and insulin, but not EGF, at physiological concentrations. These growth factors are also able to inhibit binding and degradation of one another by the enzyme. Although there are significant immunological differences between the mammalian and Drosophila enzymes, the substrate specificity has been highly conserved. These results demonstrate the existence of a selective TGF-alpha-degrading enzyme in both Drosophila and mammalian cells. The evolutionary conservation of the ability to degrade both insulin and TGF-alpha suggests that this property is important for the physiological role of the enzyme and its potential for regulating growth factor levels.

Indexed as

Biological EvolutionAnimalsCell LineDrosophilaInsulinInsulysinKineticsLiverPeptide HydrolasesRatsRecombinant ProteinsSpecies SpecificitySubstrate SpecificityTransforming Growth FactorsInsulinInsulysinPeptide HydrolasesRecombinant ProteinsTransforming Growth Factors

Identifiers

PMID2670957
PMCPMC2115746
OpenAlexW2131579868

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.